COVID-19 mRNA Vaccine Boosts Survival Rate In Some Cancer Patients, Study Finds

Forbes·Oct 23

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

A study has found that covid-19 mRNA vaccines may improve survival rates in some cancer patients. The vaccines may also enhance the effectiveness of certain cancer treatments, such as immunotherapy. The extent of the potential benefit varies, with some reports suggesting it could double survival rates in aggressive cancers, although the details and outcomes are still being reported and clarified.

Full coverage

SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade

Nature·Oct 22

Can a COVID-19 Shot Boost Cancer Immunotherapy?

City of Hope·Apr 23

COVID-19 mRNA Vaccines May Boost Immunotherapy, Doubling Survival in Aggressive Cancers

Inside Precision Medicine·Oct 20

Could COVID-19 mRNA vaccines help treat cancer?

Oncology Central·Oct 30

Study suggests mRNA COVID-19 vaccines can improve chances of cancer survival

Gavi, the Vaccine Alliance·Oct 31

COVID mRNA vaccines may be able to train immune system to attack cancer cells, boost survival

CIDRAP·Oct 20

Cancer patients who got a COVID vaccine lived much longer

ScienceDaily·Oct 19

mRNA Covid shots may boost the effects of certain cancer treatments, study suggests

STAT·Oct 19

View original report at Forbes ↗

Fetching the latest headlines…